Advances in Study on Novel Oral Biological Agents in Treatment of Inflammatory Bowel Disease
10.3969/j.issn.1008-7125.2017.08.013
- VernacularTitle:新型口服生物制剂治疗炎症性肠病的研究进展
- Author:
Yi ZHOU
;
Jun SHEN
;
Zhihua RAN
- Keywords:
Inflammatory Bowel Disease;
Crohn Disease;
Colitis;
Ulcerative;
Biological Agents;
Administration;
Oral
- From:
Chinese Journal of Gastroenterology
2017;22(8):498-501
- CountryChina
- Language:Chinese
-
Abstract:
As a new therapy in past twenty years,biological agents have been approved for the treatment of inflammatory bowel disease (IBD). However,biological agents currently used for IBD treatment require intravenous or subcutaneous injections,and some require infusion under close observation. Therefore,it is of positive clinical significance to find a safe and effective oral biological agent. This article reviewed recent advances in study on novel oral biological agents in the treatment of IBD.
